How The Trade Desk Smashed Its Own Targets -- Again

US President Donald Trump and Mark Milley, who was chairman of the Joint Chiefs of Staff at the time the picture was taken. Mark Wilson/Getty ImagesMark Milley's Pentagon portrait was removed shortly after Trump took office. Milley was hired by Trump as a top military advisor only to later fall out of favor.

Melania Trump and Usha Vance wore eye-catching gowns to the inaugural balls. Jim WATSON/AFP/Andrew Harnik/Getty ImagesThe 2025 inauguration culminated with the inaugural balls. The first and second families attended in eveningwear, but some looks were better than others. Melania Trump and Usha Vance's gowns were stunning, while Tiffany Trump's dress fell flat.

Donald Trump vowed to deport millions of immigrants in his second term.iStock; Rebecca Zisser/BIDonald Trump has vowed to deport millions of immigrants in his second term. A recent analysis estimated that his plan could drain billions in Social Security tax revenue. Many older Americans rely on Social Security to afford essentials.

Outside the JPMorgan headquarters in Manhattan. Momo Takahashi / Business InsiderInvestment banks are hiring for 2026 summer interns, including Goldman Sachs and JPMorgan. First-round interviews are underway in some cases, Business Insider has learned. Here's how to ace the HireVue screening process and score a competitive Wall Street internship. The annual race for summer investment-banking internships is kicking off across Wall Street.

By BERNARD CONDON, AP Business Writer NEW YORK (AP) — Right-wing extremists are celebrating Elon Musk’s straight-arm gesture during a speech Monday, although his intention wasn’t totally clear and some hate watchdogs are saying not to read too much into it. “I just want to say thank you for making it happen,” Musk said during a speech at Capitol One Arena on Monday afternoon, referring to Donald Trump’s victory in the presidential election.

Google DeepMind spinoff Isomorphic Labs expects testing on its first AI-designed drugs to begin this year, as tech startups race to turn algorithmic magic into actual treatments. “We’ll hopefully have some AI-designed drugs in clinical trials by the end of the year,” the firm’s Nobel Prize-winning CEO Demis Hassabis told a panel at the World Economic Forum in Davos this week.